ARCHIVES

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer

June 26, 1987